Cisplatin has been associated with hearing damage. It is usually irreversible, bilateral, and
characterized by high-frequency sensorineural hearing loss. This study was carried out to
identify impairment of hearing function in children and adolescents with cancer after cisplatin
therapy. Twenty-three survivors of childhood cancer treated with cisplatin at our Unit from
1991 to 2004 performed tympanometry, pure tone audiometry, transient otoacoustic
emissions, and distortion product otoacoustic emissions (DPOAE). The median age at …